Pharma

Your Article Summary

See Latest Articles

Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2010
Array BioPharma, 11/03/09

Array reported revenue of $7.9 million for the first quarter of fiscal 2010, compared to revenue of $5.7 million for the same period in fiscal 2009. Array invested $19.2 million in proprietary research and development during the quarter to advance its seven wholly–owned drugs in clinical development and select discovery programs. This compares to $24.5 million invested in research and development during the first quarter of fiscal 2009. Array reported a net loss of $24.8 million, or ($0.52) per share, for the first quarter, compared to a net loss of $33.7 million, or ($0.71) per share, for the first quarter in fiscal 2009.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

HP to Acquire Networking Firm 3Com
HealthDataManagement, 11/20/09

Protox Reports 2009 Third Quarter Results
Protox Therapeutics , 11/18/09

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
King Pharmaceuticals, 11/16/09

 See all of Financial Reports